YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Vytorin
Vytorin Prescriptions Still Lag
Mar 20, 2008 | Parker Waichman Alonso LLP
Vytorin prescriptions have yet to recover from the dive they took in January, following the release of a study that showed the expensive...
More Heat for Vytorin and Avandia
Mar 5, 2008 | Parker Waichman Alonso LLP
Avandia and Vytorin are the subject of yet another government investigation. The Government Accountability Office (GAO) will look into whether...
Vytorin Prescriptions Down Again After Brief Reprieve
Feb 20, 2008 | Parker Waichman Alonso LLP
Vytorin prescriptions have fallen again, dashing hopes at Merck and Schering-Plough that the fallout from a disappointing Vytorin study was starting...
Vytorin Revelations Lead to Cholesterol Debate
Feb 5, 2008 | Parker Waichman Alonso LLP
The Vytorin debacle has sparked some in the medical community to reassess the importance of controlling LDL – so-called bad –cholesterol...
Vytorin Lawsuits Keep Coming
Feb 4, 2008 | Parker Waichman Alonso LLP
Vytorin makers Merck and Schering-Plough are facing yet another lawsuit, this time from the plaintiffs in Nevada. The Nevada Vytorin consumer...
Vytorin in Connecticut Crosshairs
Jan 29, 2008 | Parker Waichman Alonso LLP
Connecticut can now be added to the list of states investigating Vytorin. According to The Wall Street Journal, Connecticut Attorney General...
Vytorin Mess Attracts Attention of New York Attorney General
Jan 28, 2008 | Parker Waichman Alonso LLP
The Vytorin mess seems to be getting worse for Merck and Schering-Plough. Already facing a firestorm over its handling of the so-called ENHANCE...
Vytorin Latest Drug Scandal to Raise Questions about FDA Oversight
Jan 25, 2008 | Parker Waichman Alonso LLP
The Vytorin controversy has once again raised serious questions about the way the Food & Drug Administration (FDA) approves new drugs. At...
FDA Issues Vytorin Early Communication
Jan 25, 2008 | Parker Waichman Alonso LLP
The Food & Drug Administration (FDA) weighed in on the Vytorin controversy today by issuing an Early Communication about its ongoing reviews of...
Vytorin Support Statement Raises Questions Over American Heart Association Funding
Jan 24, 2008 | Parker Waichman Alonso LLP
Vytorin appears to have an important ally. One day after news broke that a study had shown Vytorin to be ineffective in preventing...
Vytorin
